Literature DB >> 9413232

Oxidative stress and cardiovascular disease.

R J Hoeschen1.   

Abstract

OBJECTIVE: To assess the evidence supporting the role of oxidative stress in the pathogenesis of atherosclerosis, endothelial dysfunction, platelet aggregation and heart failure, and to evaluate the status of antioxidant therapy in the clinical management of cardiovascular disease. DATA SOURCES: No attempt was made to provide insight into mechanisms of oxidative stress and the response to antioxidant intervention. Human studies were scrutinized for evidence that oxidative stress was present and whether antioxidant therapy provides clinical benefit.
CONCLUSIONS: There is ample evidence that oxidative stress is involved in the pathogenesis of atherosclerosis, endothelial dysfunction, platelet aggregation and heart failure. However, the extrapolation of this evidence to the use of antioxidant therapy in primary or secondary prevention of cardiovascular disease cannot be justified at this time.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9413232

Source DB:  PubMed          Journal:  Can J Cardiol        ISSN: 0828-282X            Impact factor:   5.223


  10 in total

Review 1.  Serum uric acid is not an independent risk factor for coronary heart disease.

Authors:  S G Wannamethee
Journal:  Curr Hypertens Rep       Date:  2001-06       Impact factor: 5.369

2.  A dose-response study of arsenic exposure and markers of oxidative damage in Bangladesh.

Authors:  Kristin N Harper; Xinhua Liu; Megan N Hall; Vesna Ilievski; Julie Oka; Larissa Calancie; Vesna Slavkovich; Diane Levy; Abu Siddique; Shafiul Alam; Jacob L Mey; Alexander van Geen; Joseph H Graziano; Mary V Gamble
Journal:  J Occup Environ Med       Date:  2014-06       Impact factor: 2.162

3.  Scavenging free radicals improves endothelial dysfunction in human coronary arteries in vivo.

Authors:  Jun-ichi Oyama; Shinji Satoh; Nobuhiro Suematsu; Toshiaki Kadokami; Toyoki Maeda; Masahiro Sugano; Naoki Makino
Journal:  Heart Vessels       Date:  2010-07-31       Impact factor: 2.037

4.  Effects of dietary yeast Saccaromyces cerevisiae on the antioxidant system in the liver of juvenile sea bass Dicentrarchus labrax.

Authors:  Maria Pia Santacroce; Elisabetta Merra; Gerardo Centoducati; Valentina Zacchino; Elisabetta Casalino
Journal:  Fish Physiol Biochem       Date:  2012-04-08       Impact factor: 2.794

5.  High-sensitivity C-reactive protein and mean platelet volume in paediatric hypertension.

Authors:  Anna Wasilewska; Edyta Tenderenda; Katarzyna Taranta-Janusz; Walentyna Zoch-Zwierz
Journal:  Pediatr Nephrol       Date:  2010-04-23       Impact factor: 3.714

6.  Platelets oxidative stress in Indian patients with ischemic heart disease.

Authors:  Mahdi Garelnabi; Vinod Gupta; Venkatesan Mallika; Jayashree Bhattacharjee
Journal:  J Clin Lab Anal       Date:  2010       Impact factor: 2.352

7.  Oxidative stress and antioxidant defense systems in patients after heart transplantation.

Authors:  Ivan Pechan; Katarina Danova; Ingrid Olejarova; Lukac Halcak; Viera Rendekova; Juraj Fabian
Journal:  Wien Klin Wochenschr       Date:  2003-09-30       Impact factor: 1.704

Review 8.  Protective Effect of Antioxidants on Neuronal Dysfunction and Plasticity in Huntington's Disease.

Authors:  Thirunavukkarasu Velusamy; Archana S Panneerselvam; Meera Purushottam; Muthuswamy Anusuyadevi; Pramod Kumar Pal; Sanjeev Jain; Musthafa Mohamed Essa; Gilles J Guillemin; Mahesh Kandasamy
Journal:  Oxid Med Cell Longev       Date:  2017-01-12       Impact factor: 6.543

9.  Superoxide Dismutase Isoenzymes Gene Expression in Peripheral Blood Mononuclear Cells in Patients with Coronary Artery Disease.

Authors:  Ana Ninić; Nataša Bogavac-Stanojević; Miron Sopić; Jelena Munjas; Jelena Kotur-Stevuljević; Milica Miljković; Tamara Gojković; Dimitra Kalimanovska-Oštrić; Vesna Spasojević-Kalimanovska
Journal:  J Med Biochem       Date:  2019-05-11       Impact factor: 3.402

10.  Metabolomics-Based Profiling, Antioxidant Power, and Uropathogenic Bacterial Anti-Adhesion Activity of SP4TM, a Formulation with a High Content of Type-A Proanthocyanidins.

Authors:  Giuseppe Mannino; Massimo E Maffei
Journal:  Antioxidants (Basel)       Date:  2022-06-23
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.